Nearly one in five children with HIV under the age of one year who experienced an interruption in treatment in 2024 subsequently died, a review of over half a million children receiving HIV treatment through US-funded PEPFAR programmes shows. The findings were presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco on Monday.

Two broadly neutralising antibodies, teropavimab and zinlirvimab, might be good partners for lenacapavir (Sunlenca) in a long-acting HIV treatment regimen, according to study results presented yesterday at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco.

The day before the Conference on Retroviruses and Opportunistic Infections (CROI 2025) opened in San Francisco on Sunday, there was a community workshop on HIV cure science, at which Dr Michael Peluso, a local HIV physician and cure researcher, flagged up two studies to look out for.

The global HIV response is suffering serious disruption due to cuts in US government funding, the closure of USAID and a lack of clarity about future financing, Professor Chris Beyrer, Director of the Duke Global Health Institute at Duke University, North Carolina, told the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco on Monday.

Two more people appear to be free of HIV after stem cell transplants for cancer treatment, according to a pair of posters presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2025) this week in San Francisco. If the men remain in remission, they will be the eighth and ninth cases of a functional cure after the procedure.

News reporting by aidsmap will be restarting next week, under the new stewardship of Terrence Higgins Trust.

With deep regret the trustees of NAM Publications, publishers of aidsmap.com, decided in July 2024 that the charity was no longer financially sustainable. While honouring their commitment to staff, partners and service users, the trustees set about ensuring a longevity for the assets aidsmap had built up over four decades.

A survey of over half a million people in low- and middle-income countries found that men and women with disabilities were 25% less likely to have comprehensive knowledge about HIV prevention compared to people without disabilities. They were also less likely to know a place to be tested for HIV. Additionally, women with disabilities were less likely to know how to prevent vertical transmission and to have ever been tested for HIV compared to women without disabilities.

A comprehensive national effort to improve the uptake of cervical screening among women living with HIV in Uganda resulted in more than 280,000 screening visits in the second year of the campaign, up from just 6500 visits in the first six months. The proportion of women with a positive result who received treatment increased from 12% to 84% during the same period, almost achieving the 90% target set by the World Health Organization for cervical cancer elimination by 2030.

A comprehensive national effort to improve the uptake of cervical screening among women living with HIV in Uganda resulted in more than 280,000 screening visits in the second year of the campaign, up from just 6500 visits in the first six months. The proportion of women with a positive result who received treatment increased from 12% to 84% during the same period, almost achieving the 90% target set by the World Health Organization for cervical cancer elimination by 2030.

The emergence of high-level dolutegravir resistance was extremely rare in people switched to first-line dolutegravir-based treatment in Zambia and Malawi, a large prospective study has found. But the risk of having unsuppressed HIV one and two years after switching was six to seven times higher in people who switched to dolutegravir with detectable HIV. The researchers say their findings emphasise the importance of viral load monitoring before switching. The study findings are reported in Clinical Infectious Diseases.

The emergence of high-level dolutegravir resistance was extremely rare in people switched to first-line dolutegravir-based treatment in Zambia and Malawi, a large prospective study has found. But the risk of having unsuppressed HIV one and two years after switching was six to seven times higher in people who switched to dolutegravir with detectable HIV. The researchers say their findings emphasise the importance of viral load monitoring before switching. The study findings are reported in Clinical Infectious Diseases.

The day before the Conference on Retroviruses and Opportunistic Infections (CROI 2025) opened in San Francisco on Sunday, there was a community workshop on HIV cure science, at which Dr Michael Peluso, a local HIV physician and cure researcher, flagged up two studies to look out for.

The global HIV response is suffering serious disruption due to cuts in US government funding, the closure of USAID and a lack of clarity about future financing, Professor Chris Beyrer, Director of the Duke Global Health Institute at Duke University, North Carolina, told the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco on Monday.

El autobús donde iba el cantante con su orquesta de cumbia fue atacado en la madrugada del domingo.

El autobús donde iba el cantante con su orquesta de cumbia fue atacado en la madrugada del domingo.

El autobús donde iba el cantante con su orquesta de cumbia fue atacado en la madrugada del domingo.

El autobús donde iba el cantante con su orquesta de cumbia fue atacado en la madrugada del domingo.

El autobús donde iba el cantante con su orquesta de cumbia fue atacado en la madrugada del domingo.

Las organizaciones en defensa de los migrantes recomientan a los indocumentados tener listo un plan familiar que incluya quién se hará cargo de los hijos en caso de que sean arrestados y expulsados del país.